{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T04:11:25Z","timestamp":1730434285773,"version":"3.28.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[1999,7,1]],"date-time":"1999-07-01T00:00:00Z","timestamp":930787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Dapsone (4,4\u2032-diaminodiphenyl sulphone), an antileprotic and antimalarial drug, has been reported to be of therapeutic benefit in idiopathic thrombocytopenic purpura in the clinic. However, adverse reactions such as haemolytic anaemia have often been observed. In this study, we found that dapsone increased the number of platelets and decreased the number of red blood cells in male (NZW \u00d7 BXSB)F1 (W\/BF1) mice, an animal model of idiopathic thrombocytopenic purpura. In studies to prepare derivatives of dapsone with weaker side effects than the parent compound, FR115092 (2-[5-(2-pyridylsulphonyl)thiazolyl]amine) was discovered. The effect of FR115092 on the number of blood cells was studied and compared with dapsone in mice.<\/jats:p>\n               <jats:p>FR115092 increased the number of platelets without reducing the number of red blood cells in W\/BF1 mice. This drug significantly suppressed the increase in circulating autoantibodies against platelets and increased the number of megakaryocytes. Furthermore, FR115092 inhibited the reduction of the number of platelets in mitomycin C-induced thrombocytopenic mice, as a consequence of its enhancement of growth and maturation of megakaryocytes.<\/jats:p>\n               <jats:p>These findings suggest that FR115092 may be effective against various thrombocytopenias, without inducing haemolytic anaemia.<\/jats:p>","DOI":"10.1211\/0022357991773078","type":"journal-article","created":{"date-parts":[[2003,7,18]],"date-time":"2003-07-18T23:43:52Z","timestamp":1058571832000},"page":"857-865","source":"Crossref","is-referenced-by-count":1,"title":["Effects of a Novel Pyridylsulphonyl Thiazole Derivative, FR115092, on Autoimmune and Mitomycin C-induced Thrombycytopenia in Mice"],"prefix":"10.1093","volume":"51","author":[{"given":"Fusako","family":"Nishigaki","sequence":"first","affiliation":[{"name":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd , 2-1-6, Kashima, Yodogawa-ku, Osaka 532\u20138514,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Tsujimoto","sequence":"additional","affiliation":[{"name":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd , 2-1-6, Kashima, Yodogawa-ku, Osaka 532\u20138514,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Inami","sequence":"additional","affiliation":[{"name":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd , 2-1-6, Kashima, Yodogawa-ku, Osaka 532\u20138514,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanae","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd , 2-1-6, Kashima, Yodogawa-ku, Osaka 532\u20138514,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Naoe","sequence":"additional","affiliation":[{"name":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd , 2-1-6, Kashima, Yodogawa-ku, Osaka 532\u20138514,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd , 2-1-6, Kashima, Yodogawa-ku, Osaka 532\u20138514,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitaka","family":"Manda","sequence":"additional","affiliation":[{"name":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd , 2-1-6, Kashima, Yodogawa-ku, Osaka 532\u20138514,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoichi","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd , 2-1-6, Kashima, Yodogawa-ku, Osaka 532\u20138514,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,7,1]]},"reference":[{"key":"2024103110052350400_cit1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/stem.140678","article-title":"Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice","volume":"14","author":"Akahori","year":"1996","journal-title":"Stem Cells"},{"key":"2024103110052350400_cit2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0092-8674(94)90450-2","article-title":"Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor","volume":"77","author":"Bartley","year":"1994","journal-title":"Cell"},{"key":"2024103110052350400_cit3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/bjs.1800721224","article-title":"Effects of a somatostatin analogue (SMS 201-995) on hepatic and splenic reticulo-endothelial function in the rat","volume":"72","author":"Baxter","year":"1985","journal-title":"Br. J. Surg."},{"key":"2024103110052350400_cit4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0889-8588(18)30512-4","article-title":"Autoimmune thrombocytopenic purpura","volume":"4","author":"Bussel","year":"1990","journal-title":"Hematol. Oncol. Clin. North. Am"},{"key":"2024103110052350400_cit5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0002-9343(91)90661-G","article-title":"Dapsone for thrombocytopenic purpura related to human immunodeficiency virus infection","volume":"90","author":"Durand","year":"1991","journal-title":"Am. J. Med."},{"key":"2024103110052350400_cit6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2141.1991.tb04467.x","article-title":"Therapeutic developments","volume":"78","author":"Durand","year":"1991","journal-title":"Br. J. Haematol"},{"key":"2024103110052350400_cit7","first-page":"1777","article-title":"Correction of thrombocytopenia with dapsone in the primary antiphospholipid syndrome","volume":"20","author":"Durand","year":"1993","journal-title":"J. Rheumatol"},{"key":"2024103110052350400_cit8","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1182\/blood.V81.5.1284.1284","article-title":"Platelet-associated antibody to glycoprotein IIb\/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens","volume":"81","author":"Fujisawa","year":"1993","journal-title":"Blood"},{"key":"2024103110052350400_cit9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ajh.2830440117","article-title":"Dapsone for autoimmune thrombocytopenic purpura","volume":"44","author":"Godeau","year":"1993","journal-title":"Am. J. Hematol"},{"key":"2024103110052350400_cit10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2141.1995.tb05179.x","article-title":"Dapsone for refractory chronic idiopathic thrombocytopenic purpura","volume":"90","author":"Hernandez","year":"1995","journal-title":"Br. J. Haematol"},{"key":"2024103110052350400_cit11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/1040-8428(94)00128-G","article-title":"Autoimmune thrombocytopenic purpura","volume":"19","author":"Ikehara","year":"1995","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"2024103110052350400_cit12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood.V63.4.768.768","article-title":"Two-color flow cytometric measurement of DNA distributions of rat megakaryocytes in unfixed, unfractionated marrow cell suspensions","volume":"63","author":"Jackson","year":"1984","journal-title":"Blood"},{"key":"2024103110052350400_cit13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ajh.2830430110","article-title":"Pilot study of ascorbic acid for the treatment of refractory immune thrombocytopenic purpura","volume":"43","author":"Jubelirer","year":"1993","journal-title":"Am. J. Hematol"},{"key":"2024103110052350400_cit14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/blood.V56.3.329.329","article-title":"Autoimmune thrombocytopenic purpura","volume":"56","author":"Karpatkin","year":"1980","journal-title":"Blood"},{"key":"2024103110052350400_cit15","first-page":"260","article-title":"Autoimmune thrombocytopenic purpura","volume":"22","author":"Karpatkin","year":"1985","journal-title":"Semin. Hematol"},{"key":"2024103110052350400_cit16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/369568a0","article-title":"Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin","volume":"369","author":"Kaushansky","year":"1994","journal-title":"Nature"},{"key":"2024103110052350400_cit17","first-page":"896","article-title":"Cloning of murine megakaryocyte progenitor cells in a fibrin clot culture system","volume":"15","author":"Kuriya","year":"1987","journal-title":"Exp. Hematol"},{"key":"2024103110052350400_cit18","first-page":"1621","article-title":"Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow","volume":"21","author":"Laterveer","year":"1993","journal-title":"Exp. Hematol"},{"key":"2024103110052350400_cit19","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-122-10-199505150-00020","article-title":"Dapsone in thrombocytopenia of the antiphospholipid antibody syndrome","volume":"122","author":"Lesprit","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"2024103110052350400_cit20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ajh.2830460423","article-title":"Dapsone for idiopathic thrombocytopenic purpura","volume":"46","author":"Linares","year":"1994","journal-title":"Am. J. Hematol"},{"key":"2024103110052350400_cit21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/369565a0","article-title":"Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo","volume":"369","author":"Lok","year":"1994","journal-title":"Nature"},{"key":"2024103110052350400_cit22","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM198105073041904","article-title":"Chronic idiopathic thrombocytopenic purpura","volume":"304","author":"McMillan","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"2024103110052350400_cit23","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1182\/blood.V77.10.2150.2150","article-title":"Leukemia inhibitory factor can potentiate murine megakaryocyte production in vitro","volume":"77","author":"Metcalf","year":"1991","journal-title":"Blood"},{"key":"2024103110052350400_cit24","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood.V75.9.1809.1809","article-title":"Analysis of thrombocytopenia in idiopathic thrombocytopenic purpura-prone mice by platelet transfer experiments between (NZW \u00d7 BXSB) F1 and normal mice","volume":"75","author":"Mizutani","year":"1990","journal-title":"Blood"},{"key":"2024103110052350400_cit25","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood.V79.4.942.942","article-title":"Mechanisms of corticosteroid action in immune thrombocytopenic purpura (ITP): experimental studies using ITP-prone mice, (NZW \u00d7 BXSB) F1","volume":"79","author":"Mizutani","year":"1992","journal-title":"Blood"},{"key":"2024103110052350400_cit26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/s-0038-1648494","article-title":"Effects of splenectomy on immune thrombocytopenic purpura in (NZW \u00d7 BXSB) F1 mice: analyses of platelet kinetics and anti-platelet antibody production","volume":"67","author":"Mizutani","year":"1992","journal-title":"Thromb. Haemost"},{"key":"2024103110052350400_cit27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.297.6643.266","article-title":"Thrombocytopenia in systemic lupus erythematosus responsive to dapsone","volume":"297","author":"Moss","year":"1988","journal-title":"Br. Med. J"},{"key":"2024103110052350400_cit28","first-page":"563","article-title":"Phagocytosis of platelets by Kupffer cells in immune thrombocytopenia","volume":"111","author":"Neiman","year":"1987","journal-title":"Arch. Pathol. Lab. Med."},{"key":"2024103110052350400_cit29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0960-894X(97)10192-5","article-title":"Discovery of FR115092 (1998) a novel antinephritic agent","volume":"8","author":"Ogino","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2024103110052350400_cit30","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1084\/jem.167.6.2017","article-title":"(NZW \u00d7 BXSB)F1 mouse a new animal model of idiopathic thrombocytopenic purpura","volume":"167","author":"Oyaizu","year":"1988","journal-title":"J. Exp. Med."},{"key":"2024103110052350400_cit31","first-page":"279","article-title":"Therapeutic use of dapsone in idiopathic thrombocytopenic purpura","volume":"48","author":"Robert","year":"1989","journal-title":"Hawaii Med. J"},{"key":"2024103110052350400_cit32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2133.1981.tb01711.x","article-title":"Dapsone in the treatment of lupus erythematosus","volume":"104","author":"Ruzicka","year":"1981","journal-title":"Br. J. Dermatol"},{"key":"2024103110052350400_cit33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0190-9622(96)90657-X","article-title":"Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy","volume":"35","author":"Tsutsui","year":"1996","journal-title":"J. Am. Acad. Dermatol"},{"key":"2024103110052350400_cit34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2141.1993.tb04635.x","article-title":"The effects of leukemia inhibitory factor on platelet function","volume":"83","author":"Waring","year":"1993","journal-title":"Br. J. Haematol"},{"key":"2024103110052350400_cit35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/369571a0","article-title":"c-Mpl ligand is a humoral regulator of megakaryocytopoiesis","volume":"369","author":"Wendling","year":"1994","journal-title":"Nature"},{"key":"2024103110052350400_cit36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood.V64.1.156.156","article-title":"Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura","volume":"64","author":"Woods","year":"1984","journal-title":"Blood"},{"key":"2024103110052350400_cit37","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0002-9343(99)80033-3","article-title":"Case report of dapsone-related thrombocytosis in an AIDS patient","volume":"98","author":"Wynn","year":"1995","journal-title":"Am. J. Med."},{"key":"2024103110052350400_cit38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/stem.5530100105","article-title":"Effects of short-term administration of recombinant human erythropoietin on rat megakaryopoiesis","volume":"10","author":"Yonemura","year":"1992","journal-title":"Int. J. Cell Cloning"},{"key":"2024103110052350400_cit39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2141.1993.tb03020.x","article-title":"Effect of recombinant human inter-leukin-11 on rat megakaryopoiesis and thrombopoiesis in vivo: comparative study with interleukin-6","volume":"84","author":"Yonemura","year":"1993","journal-title":"Br. J. Haematol"},{"key":"2024103110052350400_cit40","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood.V84.12.4045.bloodjournal84124045","article-title":"In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells","volume":"84","author":"Zeigler","year":"1994","journal-title":"Blood"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1211%2F0022357991773078","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/51\/7\/857\/60263427\/0022357991773078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/51\/7\/857\/60263427\/0022357991773078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T10:43:12Z","timestamp":1730371392000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/51\/7\/857\/6157338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7,1]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[1999,7,1]]},"published-print":{"date-parts":[[1999,7,1]]}},"URL":"https:\/\/doi.org\/10.1211\/0022357991773078","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"type":"print","value":"0022-3573"},{"type":"electronic","value":"2042-7158"}],"subject":[],"published-other":{"date-parts":[[1999,7]]},"published":{"date-parts":[[1999,7,1]]}}}